Urinary Tract Infection -An oral administration of siddha classical drug Kollukkaivelai ver kudineer

EFFECTIVENESS OF KOLLUKKAIVELAI VER KUDINEER IN THE TREATMENT OF AZHAL NEERCHURUKKU (URINARY TRACT INFECTION) AMONG PATIENTS ATTENDING OPD GSMC, PALAYAMKOTTAI - A CASE SERIES - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/10/058379

Enrollment

Registered

2023-10-06

Start date

Unknown

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N390- Urinary tract infection, site notspecified

Interventions

Intervention1: KOLLUKKAIVELAI VER KUDINEER: DOSAGE:50ml (Twice a day orally) Intervention2: KOLLUKKAIVELAI VER KUDINEER: Dosage:50ml (Twice a day orally) for 10 days Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: Patients with symptoms of 1.Dysuria 2.Frequency 3.Urgency 4.Pain over suprapubic region 5.Hematuria 6.Recurrent UTI

Exclusion criteria

Exclusion criteria: 1.Pregnancy 2.Lactating women 3.Chronic Kidney Disease 4.Autoimmune conditions like Glomerular nephritis 5.Renal calculi 6.Hydronephrosis

Design outcomes

Primary

Measure	Time frame
The primary outcome will be reduction of less than 1,00,000 CFU/ml in urine culture and reduction of the following symptoms 1. Dysuria 2. Frequency 3. Urgency 4. Suprapubic pain 5. HematuriaTimepoint: 10 days	—

Secondary

Measure	Time frame
The secondary outcome will be the observation of siddha diagnostic parameters.Timepoint: 10 days	—

Countries

India

Contacts

Public ContactDr S Justus Antony

Government Siddha Medical College and Hospital

justusantony71@gmail.com9443090849

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026